Evaluation of Curcumin's effect on inflammation in hemodialysis patients.

Evaluation of Curcumin's effect on inflammatory markers( Erythrocyte Sedimentation Rat, Interleukin-6, Ferritin, C-Reactive Protein) in End Stage Renal Disease patient under hemodialysis

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200613047751N1

Enrollment

Registered

2020-07-05

Start date

2020-09-22

Completion date

Unknown

Last updated

2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End Stage Renal Disease. End stage renal disease

Interventions

Intervention group: Studying unites receive curcumin tablet orally once a day for 4 months. these tablets are curcuma brand of Dine company and have 475 mg curcumin..

Eligibility

Sex/Gender

All

Age

25 Years to 75 Years

Inclusion criteria

Inclusion criteria: Interest to participate in the study Suffering from chronic renal failure Lack of consumption of nonsteroidal anti-inflammatory drugs lack of consumption of Curcumin at least one month before study

Exclusion criteria

Exclusion criteria: Suffering from active cancer History of cancer Consumption of anti-coagulation drugs Suffering of inflammatory and rheumatoid diseases Suffering of active infection History of bleeding through fistula No consumption of 15 percent of tablets

Design outcomes

Primary

Measure	Time frame
Serum's level of interleukin-6. Timepoint: Before intervention and 4 months after intervention. Method of measurement: ELISA test.;Erythrocyte sedimentation rate. Timepoint: Before intervention and 4 months after intervention. Method of measurement: Modified Westergren.;Serum's level c- reactive protein. Timepoint: Before intervention and 4 months after intervention. Method of measurement: Latex Agglutinasition.;Serum's level of ferritin. Timepoint: Before intervention and 4 months after intervention. Method of measurement: chemiluminescence.	—

Measure

Time frame

Serum's level of interleukin-6. Timepoint: Before intervention and 4 months after intervention. Method of measurement: ELISA test.;Erythrocyte sedimentation rate. Timepoint: Before intervention and 4 months after intervention. Method of measurement: Modified Westergren.;Serum's level c- reactive protein. Timepoint: Before intervention and 4 months after intervention. Method of measurement: Latex Agglutinasition.;Serum's level of ferritin. Timepoint: Before intervention and 4 months after intervention. Method of measurement: chemiluminescence.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli BanagozarMohammadi

Tabriz University of Medical Sciences

alibanagozar@gmail.com+98 41 3335 5921

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026